GB9716345D0 - Therapeutic compounds - Google Patents
Therapeutic compoundsInfo
- Publication number
- GB9716345D0 GB9716345D0 GBGB9716345.5A GB9716345A GB9716345D0 GB 9716345 D0 GB9716345 D0 GB 9716345D0 GB 9716345 A GB9716345 A GB 9716345A GB 9716345 D0 GB9716345 D0 GB 9716345D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapeutic compounds
- therapeutic
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9716345.5A GB9716345D0 (en) | 1997-08-01 | 1997-08-01 | Therapeutic compounds |
| PCT/GB1998/002289 WO1999006400A1 (fr) | 1997-08-01 | 1998-07-30 | Derives de pyrazoloquinolinone utilises en tant qu'agonistes inverses du recepteur gaba alpha 5 |
| AU85520/98A AU8552098A (en) | 1997-08-01 | 1998-07-30 | Pyrazoloquinolinone derivatives as gaba alpha 5 receptor inverse agonists |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9716345.5A GB9716345D0 (en) | 1997-08-01 | 1997-08-01 | Therapeutic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB9716345D0 true GB9716345D0 (en) | 1997-10-08 |
Family
ID=10816865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB9716345.5A Pending GB9716345D0 (en) | 1997-08-01 | 1997-08-01 | Therapeutic compounds |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU8552098A (fr) |
| GB (1) | GB9716345D0 (fr) |
| WO (1) | WO1999006400A1 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2483728T3 (es) * | 2007-06-08 | 2014-08-07 | Dart Neuroscience (Cayman) Ltd | Derivados terapéuticos de pirazolonafatiridina |
| US7863266B2 (en) * | 2007-06-08 | 2011-01-04 | Helicon Therapeutics, Inc. | Therapeutic pyrazoloquinoline urea derivatives |
| EP2188284A2 (fr) * | 2007-08-14 | 2010-05-26 | Novartis Ag | Composés hétérocycliques tricycliques comme modulateurs du recepteur gaba |
| EP2188285A1 (fr) * | 2007-08-14 | 2010-05-26 | Novartis Ag | Dérivés de pyrazoloquinoléine et de pyrazolonaphtyridine comme ligands gaba alpha |
| US20150374705A1 (en) | 2012-02-14 | 2015-12-31 | Shanghai Institues for Biological Sciences | Substances for treatment or relief of pain |
| MX2014013881A (es) * | 2012-05-16 | 2015-08-14 | Archer Daniels Midland Co | Emulsificante para solubilizar solventes polares en aceites y polioles. |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0214092A1 (fr) * | 1985-08-08 | 1987-03-11 | Ciba-Geigy Ag | Absorption d'aryl-2 pyrazoloquinoléines psychoactives sous forme d'une dispersion moléculaire solide dans la polyvinylpyrrolidone |
-
1997
- 1997-08-01 GB GBGB9716345.5A patent/GB9716345D0/en active Pending
-
1998
- 1998-07-30 AU AU85520/98A patent/AU8552098A/en not_active Abandoned
- 1998-07-30 WO PCT/GB1998/002289 patent/WO1999006400A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU8552098A (en) | 1999-02-22 |
| WO1999006400A1 (fr) | 1999-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA983176B (en) | Therapeutic compounds | |
| GB9708484D0 (en) | Therapeutic agents | |
| GB9708945D0 (en) | Therapeutic agents | |
| GB9704948D0 (en) | Therapeutic agents | |
| GB9702524D0 (en) | Therapeutic agents | |
| ZA982368B (en) | New therapeutic combinations | |
| GB9711753D0 (en) | Therapeutic agents | |
| GB9713707D0 (en) | Therapeutic agents | |
| GB9715977D0 (en) | Therapeutic agents | |
| GB9711114D0 (en) | Therapeutic agents | |
| GB9600143D0 (en) | Therapeutic compounds | |
| GB9700939D0 (en) | Therapy | |
| GB9702392D0 (en) | Therapeutic agents | |
| GB9808665D0 (en) | Therapeutic compounds | |
| GB9700555D0 (en) | Therapeutic agents | |
| GB9716345D0 (en) | Therapeutic compounds | |
| GB9824897D0 (en) | Therapeutic compounds | |
| GB9716347D0 (en) | Therapeutic compounds | |
| GB9716344D0 (en) | Therapeutic compounds | |
| GB9716463D0 (en) | Therapeutic agents | |
| GB9626450D0 (en) | Therapeutic compounds | |
| GB9808667D0 (en) | Therapeutic compounds | |
| GB9705401D0 (en) | Therapeutic compounds | |
| GB9716111D0 (en) | Therapeutic compounds | |
| GB9716457D0 (en) | Therapeutic agents |